Related Experiment Video
Updated: May 17, 2026

09:53
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
Esthesioneuroblastoma as a collision tumor
K Salil Kumar1, P Muraleedharan Nampoothiri, M Venugopal
1Department of ENT, Medical College, HOD, Calicut.
Summary
This report details a rare collision tumor in the nasal cavity, combining squamous cell carcinoma and esthesioneuroblastoma. This rare presentation occurred in a patient with a history of treated uvula cancer.
Area of Science:
- Oncology
- Pathology
- Head and Neck Surgery
Background:
- Esthesioneuroblastoma is a rare malignant neoplasm affecting the nose and paranasal sinuses.
- Collision tumors, where two distinct malignancies coexist, are exceptionally uncommon in this anatomical region.
- Previous history of head and neck cancer increases the complexity of diagnosis and treatment.
Purpose of the Study:
- To report an extremely rare case of a collision tumor involving esthesioneuroblastoma and squamous cell carcinoma.
- To highlight the diagnostic and clinical challenges presented by such rare co-occurrences.
- To contribute to the literature on rare head and neck malignancies.
Main Methods:
- Histopathological examination of a nasal mass biopsy.
- Review of patient's medical history, including previous squamous cell carcinoma treatment.
- Clinical correlation of imaging and biopsy findings.
Main Results:
- Biopsy confirmed the presence of both squamous cell carcinoma and esthesioneuroblastoma within the nasal mass.
- The patient had a prior history of irradiated squamous cell carcinoma of the uvula.
- The collision tumor presented as a bleeding nasal mass.
Conclusions:
- Collision tumors of the nasal cavity, particularly with esthesioneuroblastoma and squamous cell carcinoma, are exceedingly rare.
- Accurate histopathological diagnosis is crucial for appropriate management of complex sinonasal masses.
- This case underscores the importance of considering rare diagnoses in patients with a history of prior malignancies.